Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

NCT06751108 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

NSCLC, Non Small Cell Lung Cancer

Interventions

DRUG: Corticosteroids (CS)
DRUG: Immune Checkpoint Inhibitors

Sponsor

Seoul National University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]